HOME

Welcome to the website of Lunenburg Lymphoma Phase I/II Consortium, a recently established activity of 6 Depts. of Hematology embedded in University Medical Centers here in the Netherlands. The aim of the program is to perform first in man / phase I clinical trials in hematological malignancies. In the initial phase of the program we will focus on all subtypes of non-Hodgkin lymphoma , Hodgkin lymphoma and chronic lymphocytic leukemia. Industry-sponsored trials will be the primary target. Phase II trials are in principle also eligible to be included in the LLPC program.

May we invite you to scroll through the various pages of our website. Please feel free to contact us or any other member of the LLPC for further information.

We are looking forward to hearing from you and to further explore whether any concrete collaboration in this exciting , rapidly developing field is feasible.

Regards,

Anton Hagenbeek, MD, PhD (chair), a.hagenbeek@amc.nl
Gustaaf van Imhoff, MD, PhD (co-chair), g.w.van.imhoff@int.umcg.nl
Marie José Kersten, MD, PhD (secretary), m.j.kersten@amc.nl
Martine Chamuleau, MD, PhD (treasurer), m.chamuleau@vumc.nl